Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.11 $15.83 Friday, 10th May 2024 SRRK stock ended at $13.35. This is 8.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.97% from a day low at $13.19 to a day high of $14.37.
90 days $12.81 $17.90
52 weeks $5.56 $21.17

Historical Scholar Rock Holding Corp. prices

Date Open High Low Close Volume
Aug 06, 2018 $15.14 $15.70 $15.00 $15.15 26 634
Aug 03, 2018 $15.71 $15.71 $15.10 $15.30 9 482
Aug 02, 2018 $16.50 $16.50 $14.03 $15.65 54 261
Aug 01, 2018 $16.50 $16.78 $16.02 $16.64 42 218
Jul 31, 2018 $15.92 $17.11 $15.70 $16.24 11 797
Jul 30, 2018 $15.65 $15.85 $15.44 $15.70 4 365
Jul 27, 2018 $16.00 $16.00 $15.60 $15.60 12 173
Jul 26, 2018 $15.86 $15.90 $15.25 $15.54 25 755
Jul 25, 2018 $15.15 $15.62 $15.15 $15.40 5 144
Jul 24, 2018 $15.09 $15.50 $15.05 $15.13 21 088
Jul 23, 2018 $15.43 $15.73 $15.00 $15.00 60 948
Jul 20, 2018 $15.32 $15.75 $15.24 $15.41 40 178
Jul 19, 2018 $15.20 $15.94 $15.05 $15.40 13 437
Jul 18, 2018 $15.23 $15.59 $15.05 $15.25 20 291
Jul 17, 2018 $15.46 $15.80 $15.05 $15.20 16 685
Jul 16, 2018 $15.79 $16.95 $15.21 $15.30 82 047
Jul 13, 2018 $15.94 $17.70 $15.48 $15.78 59 120
Jul 12, 2018 $15.66 $16.78 $15.26 $15.95 41 681
Jul 11, 2018 $15.25 $16.18 $15.04 $15.66 12 305
Jul 10, 2018 $14.88 $16.59 $14.81 $15.39 98 251
Jul 09, 2018 $15.23 $15.79 $14.56 $14.81 77 643
Jul 06, 2018 $15.46 $15.98 $15.00 $15.11 59 283
Jul 05, 2018 $15.10 $15.90 $14.79 $15.01 64 784
Jul 03, 2018 $14.86 $15.63 $14.80 $15.00 18 562
Jul 02, 2018 $15.69 $17.65 $14.13 $14.83 124 949
Click to get the best stock tips daily for free!

About Scholar Rock Holding Corp.

Scholar Rock Holding . Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria... SRRK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT